163 related articles for article (PubMed ID: 33661394)
1. Are there sex differences among colorectal cancer patients in treatment and survival? A Swiss cohort study.
Limam M; Matthes KL; Pestoni G; Michalopoulou E; Held L; Dehler S; Korol D; Rohrmann S
J Cancer Res Clin Oncol; 2021 May; 147(5):1407-1419. PubMed ID: 33661394
[TBL] [Abstract][Full Text] [Related]
2. It's contrary - comorbidity does not affect survival of South Africans with colorectal cancer: An analysis from the Colorectal Cancer in South Africa cohort.
Bouter C; Bebington B; Maphosa S; Maher H; Gaylard P; Etheredge HR; Fabian J; Prodehl L; Surridge D; Fourie RL; Harran N; Lutrin D; Bizos D; Ruff P
S Afr Med J; 2020 Apr; 110(5):382-388. PubMed ID: 32657722
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study.
Erichsen R; Baron JA; Stoffel EM; Laurberg S; Sandler RS; Sørensen HT
Am J Gastroenterol; 2013 Aug; 108(8):1332-40. PubMed ID: 23774154
[TBL] [Abstract][Full Text] [Related]
4. Magnitude of the Age-Advancement Effect of Comorbidities in Colorectal Cancer Prognosis.
Boakye D; Walter V; Jansen L; Martens UM; Chang-Claude J; Hoffmeister M; Brenner H
J Natl Compr Canc Netw; 2020 Jan; 18(1):59-68. PubMed ID: 31910379
[TBL] [Abstract][Full Text] [Related]
5. Impact of comorbidities at diagnosis on the 10-year colorectal cancer net survival: A population-based study.
Michalopoulou E; Matthes KL; Karavasiloglou N; Wanner M; Limam M; Korol D; Held L; Rohrmann S
Cancer Epidemiol; 2021 Aug; 73():101962. PubMed ID: 34051687
[TBL] [Abstract][Full Text] [Related]
6. Effects of newly developed chemotherapy regimens, comorbidities, chemotherapy-related toxicities on the changing patterns of the leading causes of death in elderly patients with colorectal cancer.
Tong L; Ahn C; Symanski E; Lai D; Du XL
Ann Oncol; 2014 Jun; 25(6):1234-42. PubMed ID: 24681607
[TBL] [Abstract][Full Text] [Related]
7. Impact of comorbidities at diagnosis on prostate cancer treatment and survival.
Matthes KL; Limam M; Pestoni G; Held L; Korol D; Rohrmann S
J Cancer Res Clin Oncol; 2018 Apr; 144(4):707-715. PubMed ID: 29417258
[TBL] [Abstract][Full Text] [Related]
8. The effect of comorbidities on outcomes in colorectal cancer survivors: a population-based cohort study.
Cuthbert CA; Hemmelgarn BR; Xu Y; Cheung WY
J Cancer Surviv; 2018 Dec; 12(6):733-743. PubMed ID: 30191524
[TBL] [Abstract][Full Text] [Related]
9. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
10. Sex Disparities in Outcomes of Early Stage Colorectal Cancer: A Population-Based Study.
Samawi HH; Yin Y; Speers CH; Cheung WY
Clin Colorectal Cancer; 2018 Dec; 17(4):e711-e717. PubMed ID: 30120076
[TBL] [Abstract][Full Text] [Related]
11. The role of comorbidities on the uptake of systemic treatment and 3-year survival in older cancer patients.
Stavrou EP; Lu CY; Buckley N; Pearson S
Ann Oncol; 2012 Sep; 23(9):2422-2428. PubMed ID: 22351742
[TBL] [Abstract][Full Text] [Related]
12. Socioeconomic and demographic inequalities in stage at diagnosis and survival among colorectal cancer patients: evidence from a Swiss population-based study.
Feller A; Schmidlin K; Bordoni A; Bouchardy C; Bulliard JL; Camey B; Konzelmann I; Maspoli M; Wanner M; Zwahlen M; Clough-Gorr KM;
Cancer Med; 2018 Apr; 7(4):1498-1510. PubMed ID: 29479854
[TBL] [Abstract][Full Text] [Related]
13. The impact of comorbidity on the overall survival and the cause of death in patients after colorectal cancer resection.
Rieker RJ; Hammer E; Eisele R; Schmid E; Högel J
Langenbecks Arch Surg; 2002 Jun; 387(2):72-6. PubMed ID: 12111258
[TBL] [Abstract][Full Text] [Related]
14. Impact of comorbidity on survival by tumour location: Breast, colorectal and lung cancer (2000-2014).
Parés-Badell O; Banqué M; Macià F; Castells X; Sala M
Cancer Epidemiol; 2017 Aug; 49():66-74. PubMed ID: 28586708
[TBL] [Abstract][Full Text] [Related]
15. Impact of Comorbidities on Survival in Gastric, Colorectal, and Lung Cancer Patients.
Morishima T; Matsumoto Y; Koeda N; Shimada H; Maruhama T; Matsuki D; Nakata K; Ito Y; Tabuchi T; Miyashiro I
J Epidemiol; 2019 Mar; 29(3):110-115. PubMed ID: 30012908
[TBL] [Abstract][Full Text] [Related]
16. Does comorbidity interact with colorectal cancer to increase mortality? A nationwide population-based cohort study.
Erichsen R; Horváth-Puhó E; Iversen LH; Lash TL; Sørensen HT
Br J Cancer; 2013 Oct; 109(7):2005-13. PubMed ID: 24022185
[TBL] [Abstract][Full Text] [Related]
17. Understanding Comorbidity Profiles and Their Effect on Treatment and Survival in Patients With Colorectal Cancer.
Hahn EE; Gould MK; Munoz-Plaza CE; Lee JS; Parry C; Shen E
J Natl Compr Canc Netw; 2018 Jan; 16(1):23-34. PubMed ID: 29295878
[No Abstract] [Full Text] [Related]
18. Association of the Charlson comorbidity index and hypertension with survival in men with metastatic castration-resistant prostate cancer.
Goyal J; Pond GR; Galsky MD; Hendricks R; Small A; Tsao CK; Sonpavde G
Urol Oncol; 2014 Jan; 32(1):36.e27-34. PubMed ID: 23685020
[TBL] [Abstract][Full Text] [Related]
19. Sex-specific differences in colorectal cancer: A multicenter retrospective cohort study.
Joo HJ; Lee HS; Jang BI; Kim DB; Kim JH; Park JJ; Kim HG; Baek IH; Lee J; Kim B
Cancer Rep (Hoboken); 2023 Aug; 6(8):e1845. PubMed ID: 37348877
[TBL] [Abstract][Full Text] [Related]
20. Effect of comorbidity assessed by the Charlson Comorbidity Index on the length of stay, costs, and mortality among colorectal cancer patients undergoing colorectal surgery.
Zhang X; Wang X; Wang M; Gu J; Guo H; Yang Y; Liu J; Li Q
Curr Med Res Opin; 2023 Feb; 39(2):187-195. PubMed ID: 36269069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
